TR201910633A1 - Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu - Google Patents

Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu Download PDF

Info

Publication number
TR201910633A1
TR201910633A1 TR2019/10633A TR201910633A TR201910633A1 TR 201910633 A1 TR201910633 A1 TR 201910633A1 TR 2019/10633 A TR2019/10633 A TR 2019/10633A TR 201910633 A TR201910633 A TR 201910633A TR 201910633 A1 TR201910633 A1 TR 201910633A1
Authority
TR
Turkey
Prior art keywords
efervesan
cytagliptin
tablet composition
sitagliptin
pharmaceutically acceptable
Prior art date
Application number
TR2019/10633A
Other languages
English (en)
Inventor
Ulusoy Bozyel Müge
Ataman Seval
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2019/10633A priority Critical patent/TR201910633A1/tr
Priority to PCT/TR2020/050615 priority patent/WO2021010924A1/en
Priority to EP20841192.6A priority patent/EP3999070A4/en
Publication of TR201910633A1 publication Critical patent/TR201910633A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

Mevcut buluş; sitagliptin veya sitagliptinin farmasötik olarak kabul edilebilir bir tuzunu, solvatını veya polimorfunu ve en az bir farmasötik olarak kabul edilebilir eksipiyan içeren bir efervesan tablet formülasyonu ile ilgilidir. Ayrıca mevcut buluş, söz konusu tableti hazırlama yöntemi de sunmaktadır.
TR2019/10633A 2019-07-17 2019-07-17 Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu TR201910633A1 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2019/10633A TR201910633A1 (tr) 2019-07-17 2019-07-17 Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu
PCT/TR2020/050615 WO2021010924A1 (en) 2019-07-17 2020-07-10 An effervescent tablet composition of sitagliptin
EP20841192.6A EP3999070A4 (en) 2019-07-17 2020-07-10 SITAGLIPTIN EFFERVESCENT TABLET COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/10633A TR201910633A1 (tr) 2019-07-17 2019-07-17 Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu

Publications (1)

Publication Number Publication Date
TR201910633A1 true TR201910633A1 (tr) 2021-05-21

Family

ID=74209853

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/10633A TR201910633A1 (tr) 2019-07-17 2019-07-17 Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu

Country Status (3)

Country Link
EP (1) EP3999070A4 (tr)
TR (1) TR201910633A1 (tr)
WO (1) WO2021010924A1 (tr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2586782B2 (en) * 2008-07-03 2017-10-04 ratiopharm GmbH Crystalline salts of sitagliptin
WO2013077819A1 (en) * 2011-11-23 2013-05-30 Mahmut Bilgic Pharmaceutical formulations comprising nateglinide
WO2013115744A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin)
IN2014MU00651A (tr) 2014-02-25 2015-10-23 Cadila Healthcare Ltd
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Also Published As

Publication number Publication date
EP3999070A4 (en) 2023-08-16
WO2021010924A1 (en) 2021-01-21
EP3999070A1 (en) 2022-05-25

Similar Documents

Publication Publication Date Title
EA201891099A1 (ru) 7-(тиазол-5-ил)пирролопиримида в качестве агониста рецептора tlr7
WO2017112917A8 (en) Methods of treating cancer
TR201901312T4 (tr) Mcl-1 proteinini inhibe eden tetrahidronaftalen türevleri.
BR112018002499A2 (pt) método de preparação de um composto da fórmula (a) ou um seu sal, solvato ou conjugado de aminoácido farmaceuticamente aceitável, composto produzido pelo método e composição farmacêutica
EA201892007A1 (ru) 3-дезоксипроизводное и фармацевтические композиции на его основе
PH12016502103A1 (en) Novel disubstituted 1,2, 4-triazine compound
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
PH12019501639A1 (en) Jaki selective inhibitors
SA520411635B1 (ar) A2a مشتق حلقي مدمج كمثبط مستقبل
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
EA201791600A1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
MX2020010618A (es) Derivados de pirazolotriazolopiriminina como antagonista del receptor a2a.
MX2019012454A (es) Compuesto solido cristalino novedoso de clorhidrato de 3-fenil-4-propil-1-(piridin-2-il)-1h-pirazol-5-ol.
EA201700356A1 (ru) Новые циклопропанбензофуранилпиридопиразиндионы
EP3582759A4 (en) BIOEQUIVALENT PHARMACEUTICAL COMPOSITION OF PRE-ORDIOXETINE HYDROBROMIDE
EA201591717A1 (ru) Твердые формы гидрохлорида вемурафениба
EA201890896A1 (ru) Твердый препарат для перорального применения, содержащий аморфный солифенацин, и способ его получения
TR201722603A2 (tr) Metformi̇n ve si̇tagli̇pti̇n i̇çeren sicak eri̇tme ekstrüzyonu i̇le gerçekleşti̇ri̇len tablet formülasyonlari
MX2022005951A (es) Compuestos de pirrolotriazina que actuan como inhibidor de mnk.
CL2020001461A1 (es) Inhibidores de dopamina–b–hidroxilasa.
EA201891319A1 (ru) Соединения алкилдигидрохинолинсульфонамида
BR112021018372A2 (pt) Composto acilaminopirrolo-piridona, método para preparar o referido composto, composição farmacêutica e uso do mesmo
TR201910633A1 (tr) Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu
EA202190328A1 (ru) Фармацевтическая композиция, содержащая тикагрелор
TR201821114A2 (tr) Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m